TrialNature medicine2024

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial.

Michael C Heinrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.